Top Glove’s 1QFY15’s MYR48.7m net profit was broadly in line at 26%/25% of our/consensus full-year estimates respectively. We maintain our BUY call and MYR5.06 TP (17.7% upside) based on 17x FY15F P/E. Earnings growth of 6% QoQ was driven by higher sales volume. Nevertheless, lower ASPs for the quarter resulted in softer revenue figures.
Results in line. Top Glove’s 1QFY15 (Aug) earnings were in line with our and consensus estimates, making up 26% of our full-year forecast. Although revenue fell 2.2% QoQ, led by lower ASPs due to the falling cost of raw materials, earnings were up 6.1 QoQ. EBITDA margin improved to 14.2% from the previous quarter’s 10.2%.
Decreasing cost of raw materials. Prices of natural and nitrile latex, the two key components of rubber gloves manufacturing, have fallen YoY. Natural latex has fallen 24.5% to an average of MYR3.90 per kg while nitrile latex has contracted 1% to an average of USD1.04 per kg. Nevertheless, as is the convention in the glove industry, savings gained from these were shared with customers.
Ramping up of nitrile capacity. Top Glove is on track with its expansion blueprint, where 14 new lines are expected to be completed in Jan 2015. This will introduce an additional 2bn (or 20%) nitrile glove capacity. By Sep 2016, the company is expected to add 42 lines in total, bringing total capacity up to 49bn pieces (Nov 2014: 42.6bn).
Falling MYR. The recent weakness of the MYR against the USD is expected to benefit Top Glove, as selling prices are quoted in USD while cost is denominated in MYR.
Maintain BUY and MYR5.06 TP. The recent sell down has led to Top Glove being traded at attractive valuations. It is now trading at 14.4x FY15F P/E. The company has solid fundamentals, ie a robust balance sheet, healthy cash flow and decent dividend yields of 3.5-3.7%. We maintain our MYR5.06 TP based on 17x FY15F P/E, which is the mean of its historical trading band.
Financial Exhibits
Financial Exhibits
SWOT Analysis
Company Profile
Top Glove Corp (Top Glove) is an investment holding company. The principal activities of its subsidiaries are the manufacturing and sale of medical gloves
Recommendation Chart
Source: RHB
Chart | Stock Name | Last | Change | Volume |
---|
Created by kiasutrader | Jun 14, 2016
Created by kiasutrader | May 05, 2016